securities fraud

ImmunityBio faces securities lawsuit over allegedly misleading Anktiva promotional materials. Stock fell 21% after FDA warning letter; investors can seek lead plaintiff status.

Rosen Law Firm investigates ADMA Biologics for allegedly misleading investors. Stock fell 16.6% after short seller Culper Research alleged channel stuffing to inflate revenue.

Power Solutions International faces class action lawsuit alleging material misstatements about data center sales projections and manufacturing costs between May 2025 and March 2026.

Hagens Berman sues $GEMI, alleging IPO documents concealed corporate pivot to prediction markets and executive departures. Stock plunged 75% from $28 IPO price.

Class action lawsuit filed against $ODD for allegedly concealing advertising partner algorithm changes that drove up customer acquisition costs, triggering 49% stock plunge.

Driven Brands Holdings admits accounting failures, misses SEC filings. Class action lawsuit filed; investors can claim lead plaintiff status before May 8 deadline.

Soleno Therapeutics faces class action lawsuit over safety concerns and inflated metrics for flagship drug VYKAT™ XR. Stock plunged 27% following August short report and November earnings disappointment.

Gemini Space Station faces securities fraud class action over IPO misstatements. Stock plummeted 79% following February restructuring and executive departures. Lead plaintiff deadline: May 15, 2026.

Nektar Therapeutics faces securities fraud lawsuit over failed alopecia trial and alleged protocol disclosure violations. Stock fell 7.8% on December 16, 2025.

Gemini Space Station faces securities fraud lawsuit after stock plummeted from $28 IPO to $5.96, following revelations of false statements about crypto platform viability.

Class action lawsuit filed against $CIGL for alleged fraudulent stock promotion involving social media misinformation and insider share dumping via offshore accounts.

Medpace faces class action lawsuit over allegedly inflated book-to-bill ratio claims during April 2025-February 2026 period; lead plaintiff deadline set for June 5, 2026.

Lawsuit alleges $BW executives made false statements about business operations and undisclosed conflicts of interest in major contracts.

Class action lawsuit filed against Fitness Champs ($FCHL) alleging market manipulation via social media fraud. Investors have until June 16, 2026 to seek lead plaintiff status.

Class action lawsuit filed against Driven Brands ($DRVN) alleges securities fraud, unreconciled cash balances, and accounting control failures affecting fiscal 2023-2024.

Nektar Therapeutics faces class action suit alleging REZOLVE-AA trial protocol violations. Investors urged to act by May 2026 deadline.

Class action lawsuit filed against Super Micro Computer alleging undisclosed China sales violating export controls and concealed compliance weaknesses. Lead plaintiff deadline: May 26, 2026.

Apollo Global Management faces class action lawsuit over alleged false statements about Epstein dealings. Investors who purchased securities May 2021-February 2026 may be eligible to join.

Class action lawsuit filed against Lufax Holding ($LU) alleging securities fraud, false statements, and inadequate internal controls spanning April 2023 to January 2025.

Class action lawsuit filed against Pinterest alleging false statements on ad revenue decline, tariff management, and undisclosed restructuring plans affecting investors.